If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 41 - 50 of 279
Single-Arm Study of Toripalimab in Combination with Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants (TRANSPARENT)
Objective
Study of toripalimab for recurrent metastatic nasopharyngeal carcinoma treatment naive patients
Protocol No
RTOG-FND-3521-CHS-007-01
Categories
REALITI-N: A Multinational, Observational Study to Evaluate the Real-World Effectiveness of Mepolizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Objective
Mepolizumab in CRSwNP
Protocol No
OTO-GSK-REALITI-N
Categories
REal World ExperieNce With BRIUMVI® (UblituximAB-xiiy) Treated Patients: A Longitudinal REgistry Study (ENABLE)
Objective
Real World Experience with BRIUMVI for Relapsing MS
Protocol No
NEURO-TG-ENABLE
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Objective
Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis
Protocol No
PULM-UNITED-TETON-PPF
Categories
A Randomized Study Comparing the Efficacy of the Combination of Doxorubicin and the Tumor-Targeting Human Antibody-Cytokine Fusion Protein L19TNF to Doxorubicin Alone as First-Line Therapy in Patients with Metastatic Leiomyosarcoma
Objective
L19TNF treatment of metastatic soft tissue sarcoma patients
Protocol No
PHILOGEN-PH-L19TNFDOX2-02-17
IMPRoving Outcomes in Vascular DisEase- Aortic Dissection
Objective
IMPRoving Outcomes in Vascular DisEase- Aortic Dissection
Protocol No
SURG-DUKE-IMPROVE-AD
A Randomized, Open-Label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants with Endometrial Cancer Who Have Received Prior Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Objective
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/​GOG-3104/​ENGOT-en26) (ASCENT-GYN-01)
Protocol No
GOG-3104-GILEAD-GS-US-682-6769
Categories
Neural Representation of Lexical Concepts - functional MRI
Objective
Neural Representation of Lexical Concepts - fMRI
Protocol No
NEURO-IIT-FERNANDINO-NEUROLEX
Comparison of Continuous Glucose Monitor and OGTT as a screen for CFRD and Impaired Glucose Tolerance in Cystic Fibrosis
Objective
CGM and OGTT Screen for CFRD
Protocol No
PULM-IIT-BILLER-CGMCFRD
Categories
Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
Objective
Testing a narrower margin in surgery for patients with primary cutaneous melanoma
We are doing this study because we want to find out if this approach is better or worse than the usual approach for melanoma surgery. The usual approach is defined as care most people get for melanoma.
We are doing this study because we want to find out if this approach is better or worse than the usual approach for melanoma surgery. The usual approach is defined as care most people get for melanoma.
Protocol No
SWOG-S2015
Categories